Drug Profile


Alternative Names: R 89439

Latest Information Update: 24 Sep 1997

Price : $50

At a glance

  • Originator Janssen L.P.
  • Class Acetamides; Acetophenones; Antiretrovirals; Small molecules
  • Mechanism of Action RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 24 Sep 1997 Discontinued-II for HIV infections treatment in Belgium (PO)
  • 06 Dec 1994 A study was added to the Therapeutic Trials section
  • 30 Nov 1994 A clinical study was added to the drug interactions section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top